Palisades Investment Partners, LLC Veracyte, Inc. Transaction History
Palisades Investment Partners, LLC
- $229 Billion
- Q2 2025
A detailed history of Palisades Investment Partners, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 162,408 shares of VCYT stock, worth $3.93 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
162,408
Previous 167,142
2.83%
Holding current value
$3.93 Million
Previous $4.96 Billion
11.42%
% of portfolio
1.92%
Previous 2.49%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
305Shares Held
79.4MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$189 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$127 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$95.4 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$93.3 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.73B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...